The Hillsborough-based company provides instrument-tracking software and last raised capital in 2017. At that time, the company did not have a website, but it had filed for a trademark, noting it produced hardware and software for “generating and manipulating” images taken by medical devices.
“We want to make surgery faster without compromising on accuracy, we want to make surgery safer without compromising on efficiency, we want to make surgery better and we’ve done that with TrackX,” a statement from company CEO and founder Robert Isaacs, M.D., reads on the company’s website.
The website also notes that the company’s technology can reduce the number of required x-rays by 74.8%, reduce radiation exposure by 91.8%, and reduce the overall time of surgery by 56 minutes.
One product the company provides is TrackX Snaps, which the company website states “were created as a universal solution for visual guidance and real-time instrument tracking of various surgical instruments and implants.”
According to the filing, proceeds from the sale will be used for working capital. The company first sold equity in May 2021, according to the filing.